Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSteppe Cement Regulatory News (STCM)

Share Price Information for Steppe Cement (STCM)

Share Price is delayed by 15 minutes
Get Live Data
19.50    0.00 (0.00%)
Bid:
19.00
Ask:
20.00
Spread: 1.00 (5.263%)
Market Cap: £42.70m
STCM Live PriceLast checked at - London Stock Exchange

Intraday Steppe Cement Share Chart

Trading Update for Q3 2024

14 Oct 2024 07:00

RNS Number : 9762H
Steppe Cement Limited
14 October 2024
Β 

14 October 2024

Β 

Steppe Cement Ltd

("Steppe Cement" or the "Company")

Trading Update for the Third Quarter ended 30 September 2024

Steppe Cement Ltd (AIM: STCM), is pleased to announce the following trading update for the third quarter ended 30 September 2024 ("Q3 2024" or the "Period"). All numbers referenced below are unaudited.

Β· Steppe Cement generated revenue of KZT 15,085 million (approximately USD 32 million) in Q3 2024, which was 7% higher than the revenue achieved in Q3 2023 of KZT 14,116 million (approximately USD 31 million).

Β· For the nine months ended 30 September 2024, Steppe Cement recorded revenue of KZT 30,520 million (approximately USD 67 million) compared with KZT 31,093 million (approximately USD 69 million) in the corresponding nine-month period in 2023 (a 2% decrease).

Β· The increased revenue in the 3 months to 30 September 2024 was largely attributable to the increase in the volume of sales during the period to 621,915 tonnes, 5% higher than in 2023 as well as a 2% increase in the price of products sold in the quarter.

Β· For the first 9 months of 2024, the volume of sales remained at 1.34 million tonnes

Β· The average price (ex-VAT) for delivered cement was KZT 22,755 (approximately USD 50) per tonne in the first 9 months, compared with KZT 23,163 (approximately USD 51) per tonne in the corresponding period in 2023.

Β· Production levels have increased due to the increased efficiencies resulting from the capex spent over the previous last two years. Higher production levels helped to stabilize the cost base as well as to increase the clinker stock available for the fourth quarter.

Β· Steppe Cement has cash and cash equivalents of USD 11 million, as at 7 October 2024.

For the first nine months of 2024, the demand for cement in the domestic market was 9.1 million tonnes, similar to 2023. In the first 9 months of 2024, imports into Kazakhstan decreased to 3.5% of total consumption down from 4.6% in the corresponding period in 2023, while exports from Kazakhstan were 0.72 million tonnes in the 9 months to 30 September 2024 due to higher competition in Uzbekistan. The current estimate of the cement market for the full year of 2024 is 11.3 million tonnes, the same as in 2023.

Steppe Cement's market share is expected to stay at around 15%.

Javier del Ser Perez, Chief Executive Officer of Steppe Cement, commented:

Β "We recovered both volumes and pricing in the third quarter of 2024, following a price adjustment in the second quarter. While competition remains strong, our factory has continued to enhance its capacity and productivity, enabling us to offset the impact of past inflation. We remain focused on driving higher volumes and cash generation."

**Ends**

For further information, please contact:

Steppe Cement Ltd www.steppecement.com

Javier del Ser PΓ©rez, Chief Executive Officer Tel: +(603) 2166 0361

Strand Hanson Limited (Nominated & Financial Adviser and Broker) Β ww.strandhanson.co.uk

James Spinney / Robert Collins / Ritchie Balmer Tel: +44 20 7409 3494

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended by virtue of the Market Abuse (Amendment) (EU Exit) Regulations 2019.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTFFLEFDELSEDS
Date   Source Headline
26th Jun 20261:01 pmRNSResult of AGM
22nd Jun 20267:00 amRNSAGM - Submission of Shareholder Questions
27th May 20267:00 amRNSNotice of AGM
27th May 20267:00 amRNSAnnual Financial Report
10th Apr 20267:00 amRNSTrading Update for the Quarter ended 31 March 2026
19th Jan 20268:03 amRNSInvestor Presentation via Investor Meet Company
15th Jan 20263:02 pmRNSReplacement - Trading Update
15th Jan 202610:45 amRNSTrading Update, Board Changes and Investment Plan
29th Dec 20257:00 amRNSCapital Repayment Payment Date
29th Dec 20257:00 amRNSCapital Repayment Payment Date
9th Dec 202510:30 amRNSCapital Repayment Record Date
5th Dec 20259:17 amRNSResult of EGM
14th Nov 20257:00 amRNSProposed Reduction & Repayment of Capital and EGM
17th Oct 20257:00 amRNSTrading Update for Q3 2025
15th Sep 20257:00 amRNSHalf-year Report
25th Jul 202511:07 amRNSResult of AGM
21st Jul 20251:34 pmRNSAGM – Submission of Shareholder Questions
7th Jul 20258:00 amRNSTrading Update
26th Jun 20257:55 amRNSNotice of AGM
26th Jun 20257:54 amRNSAnnual Financial Report
8th Apr 20258:29 amRNSTrading update for the quarter ended 31 March 2025
14th Jan 20257:00 amRNSYear End Trading Update
2nd Jan 202510:00 amRNSCapital Repayment Payment
12th Dec 20247:00 amRNSCapital Repayment Record Date
6th Dec 20248:39 amRNSResult of EGM
15th Nov 20247:00 amRNSProposed Reduction & Repayment of Capital and EGM
14th Oct 20247:00 amRNSTrading Update for Q3 2024
4th Oct 20249:15 amRNSHolding(s) in Company
20th Sep 20247:00 amRNSHalf-year Report
6th Aug 20248:21 amRNSDirector's Dealing
2nd Aug 20249:44 amRNSDirector's Dealing
12th Jul 202410:08 amRNSResult of AGM and Market Update for H1 2024
4th Jul 20247:00 amRNSAGM - Submission of Shareholder Questions
19th Jun 20247:00 amRNSNotice of AGM
19th Jun 20247:00 amRNSAnnual Financial Report
23rd May 20247:00 amRNSCapital Repayment Record Date
26th Apr 20249:53 amRNSResult of EGM
9th Apr 20249:42 amRNSDirector's Dealing
5th Apr 20247:01 amRNSProposed Return of Cash to Shareholders and EGM
5th Apr 20247:00 amRNSTrading update for the quarter ended 31 March 2024
12th Jan 202410:15 amRNSYear End Trading Update
13th Dec 20239:15 amRNSUpdate re intention to pay a dividend
28th Nov 202311:44 amRNSDirector's Dealing
23rd Nov 20237:41 amRNSDirector's Dealing
11th Oct 20239:44 amRNSMarket Update for the Third Quarter September 2023
20th Sep 202310:19 amRNSDirector's Dealing
19th Sep 20239:00 amRNSHalf-year Report
13th Jul 20237:00 amRNSResult of AGM
12th Jul 20237:00 amRNSMarket Update - First half of 2023
4th Jul 20237:00 amRNSNotice of AGM and Submissions of Questions

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.